Understanding heterogeneity of treatment response in standard risk acute myeloid leukaemia

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/201630/04/2021

Collaborative partners

Funding

  • Blood Cancer UK: £275,279.00
  • Blood Cancer UK: £45,206.00